Parliament Workbench
Data: Motions & questions to 26 Nov 2026

Written Question · S2W-19555 · Session 2

What account it took of epidemiological studies into the links between cholesterol and dementia when framing guidance for doctors on choles…

Answered Asked by Linda Fabiani SNP Lodged 29 Sep 2005

The question

To ask the Scottish Executive what account it took of epidemiological studies into the links between cholesterol and dementia when framing guidance for doctors on cholesterol levels in patients.

The answer

Answered by Lewis Macdonald on 27 Oct 2005 · 28 days after it was lodged, on time

An article in The Lancet last month stated that cholesterol reducing statins may be useful in delaying or preventing the onset of dementia. I am also aware of the research (published by Dr. Thomas D. Rea et al at the University of Washington in July 2005 in the Archives of Neurology) which did not find sufficient evidence that statin use reduced the risk of dementia. The abstract of this research can be found at http://archneur.ama-assn.org/cgi/content/abstract/62/7/1047.
High cholesterol is one of the key risk factors for chronic heart disease (CHD). Statins are widely used to reduce cholesterol for patients who are at particularly high risk of developing heart disease. Evidence based guidelines on lipids and the primary prevention of CHD were issued by the Scottish Intercollegiate Guidelines Network in September 1999.

In the Official Report

No contribution in the Official Report cites S2W-19555 by reference.